First Line Therapy for Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
- Status
- TERMINATED
- Phase
- PHASE2
VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
VEGF Trap in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A